[1]
Dang, B.N. et al. 2026. CLINICAL, PARACLINICAL FEATURES, OUTCOMES, AND ASSOCIATED FACTORS OF DOSE-DENSE 4AC–4P ADJUVANT CHEMOTHERAPY IN HIGH-RISK BREAST CANCER. Cantho Journal of Medicine and Pharmacy. 102 (Aug. 2026), 35–42. DOI:https://doi.org/10.58490/ctjump.2026i102.4748.